门脉高压症的检查选择与病因诊断*

doi:10.3969/j.issn.1672-5069.2018.03.001

Abstract

Chen Shiyao, Huang Xiaoquan, Ceng Xiaoqing. Etiology and diagnosis of portal hypertension[J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2018, 21(3): 321-324.

[1] Procope B,Tantau M,Bureau C.Are there any alternative methods to hepatic venous pressure gradient in portal hypertension assessment. J Gastrointest Liver Dis,2013,22(1):73.
[2] Garcia-Tsao G,Abraldes JG,Berzigotti A,et al.Portal hypertensive bleeding in cirrhosis:Risk stratification,diagnosis,and management:2016 practice guidance by the American Association for the study of liver diseases. Hepatology,2017,65(1):310-335.
[3] Hillaire S,Bonte E,Denninger MH,et al.Idiopathic non-cirrhotic intrahepatic portal hypertension in the West:a re-evaluation in 28 patients. Gut,2002,51(2):275-280.
[4] De BK,Sen S,Sanyal R.Hepatopulmonary syndrome in noncirrhotic portal hypertension. Ann Intern Med,2000,132(11):924.
[5] O’shea RS,Dasarathy S,McUllough AJ,et al. Alcoholic liver disease. Hepatology (Baltimore,Md.),2010,51(1):307-328.
[6] Feld JJ,Hussain N,Wright EC,et al.Hepatic involvement and portal hyper-tension predict mortality in chronic granulomatous disease. Gastroenterology,2008,134:1917-1926.
[7] Salkic NN,Jovanovic P,Hauser G,et al.FibroTest/Fibrosure for significant liver fibrosis and cirrhosis in chronic hepatitis B:a meta-analysis. Am J Gastroenterol,2014,109(6):796.
[8] Buck M,Garcia-Tsao G,Groszmann RJ,et al.Novel inflammatory biomarkers of portal pressure in compensated cirrhosis patients. Hepatology,2014,59(3):1052-1059.
[9] Berzigotti A,Piscaglia F.Ultrasound in portal hypertension-Part 1. Ultraschall Med,2011,32:548-571.
[10] Augustin S,Millán L,González A,et al.Detection of early portal hypertension with routine data and liver stiffness in patients with asymptomatic liver disease:a prospective study. J Hepatol,2014,60(3):561-569.
[11] Berzigotti A,Seijo S,Arena U,et al.Elastography,spleen size,and platelet count identify portal hypertension in patients with compensated cirrhosis. Gastroenterology,2013,144(1):102.
[12] Berzigotti A.Non-invasive evaluation of portal hypertension using ultrasound elastography. J Hepatol,2017,67(2):399.
[13] Caldwell S,Marchesini G. Cryptogenic vs NASH-cirrhosis:The rose exists well before its name. J Hepatology,2017[ahead of print].
[14] Procopet B,Berzigotti A.Diagnosis of cirrhosis and portal hypertension:imaging,non-invasive markers of fibrosis and liver biopsy. Gastroenterol Rep,2017,5(2):79-89.
[15] Ponziani FR,Gasbarrini A,Pompili M.Use of liver imaging and biopsy in clinical practice. New Engl J Med,2017,377(8):756.

Etiology and diagnosis of portal hypertension

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Recommended Articles

Metrics

Comments

[1]	Zhuang Ying, Lin Zhihui.. Clinical manifestations and diagnosis of portal vein thrombosis [J]. Journal of Practical Hepatology, 2019, 22(6): 765-767.
[2]	National Workshop on Fatty Liver, Alcoholic Liver Disease, Chinese Society of Hepatology; National Workshop on Liver, Metabolism, Chinese Society of Endocrinology, Chinese Medical Association. Committee of Hepatology, Chinese Research Hospital Association; Fatty Liver Expert Committee, Chinese Medical Doctor Association [J]. Journal of Practical Hepatology, 2019, 22(6): 787-792.
[3]	. Consensus on the diagnosis and therapy of hepatic fibrosis [J]. Journal of Practical Hepatology, 2019, 22(6): 793-803.
[4]	Ding Limin, Wang Fei, Piao Lianshu, et al.. Etiology of 202 patients with abnormal liver function tests [J]. Journal of Practical Hepatology, 2019, 22(6): 856-859.
[5]	Cao Ce, Yu Yixing, Wang Beibei, et al.. Clinical diagnostic efficacy of enhanced magnetic resonance imaging combined with serum AFP and PIVKA-Ⅱ in the diagnosis of patients with hepatocellular carcinoma [J]. Journal of Practical Hepatology, 2019, 22(6): 896-899.
[6]	Zeng Yanni, Zhang Can, Bi Junying, et al.. Value of long-time delayed enhancement scan of MRI in the diagnosis of solitary necrotic nodule of liver [J]. Journal of Practical Hepatology, 2019, 22(6): 900-903.
[7]	Zhang Rui, Wang Jian, Chen Shiyao.. Mechanism of portal vein thrombosis in cirrhotic patients with portal hypertension and the treatment [J]. Journal of Practical Hepatology, 2019, 22(6): 930-933.
[8]	Xing Hao, Han Jun, Yang Tian.. Diagnostic value of serum protein induced by vitamin K absence or antagonist II for hepatocellular carcinoma [J]. Journal of Practical Hepatology, 2019, 22(6): 934-937.
[9]	Liang Jubo, Miao Qi, Ma Xiong.. Diagnosis and treatment of cholangiocytic cholestasis [J]. Journal of Practical Hepatology, 2019, 22(6): 941-943.
[10]	Gao Wei, Hou Yong. Diagnostic efficacy of hepatic fibrosis by liver stiffness measurement in patients with chronic hepatitis B [J]. Journal of Practical Hepatology, 2019, 22(5): 652-655.
[11]	Huang Hanjun, Lu Fengrong, Zhang Can. Clinical value of MRI scanning based on exchange hemodynamics model in evaluating liver cirrhosis [J]. Journal of Practical Hepatology, 2019, 22(5): 696-699.
[12]	Hong Jia, Wu Xiaoning, You Hong. Standardized diagnosis of cholestatic liver diseases [J]. Journal of Practical Hepatology, 2019, 22(5): 758-760.
[13]	Cheng Hua, Ju Hui, Song Deshun et al. Value of serum angiopoietin-like protein 2 and Golgi protein 73 levels in the diagnosis of hepatic fibrosis in patient with chronic hepatitis B [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(4): 494-497.
[14]	Yu Yingfang, Wen Shengbao. Assessment of liver fibrosis with diffusion-weighted magnetic resonance imaging using single, double and stretch index model in patients with chronic hepatitis B [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(4): 502-505.
[15]	Zhang Yafei, Ye Jun, Xie Qinxiu, et al. Difference in predicting efficacy of significant liver fibrosis by noninvasive liver fibrosis index in different hospitals [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(4): 510-513.